Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
CRT 2023: Late-Breaking Data Reinforce Benefits of Abbott's Minimally Invasive Heart Devices
02/28/2023
Abbott announced late-breaking data for its next-generation Navitor™ transcatheter aortic valve implantation (TAVI) system.
Abbott announced late-breaking data for its next-generation Navitor™ transcatheter aortic valve implantation (TAVI) system.
Abbott announced late-breaking...
02/28/2023
Cath Lab Digest
News
Rutgers Researchers Use Artificial Intelligence to Predict Cardiovascular Disease
02/28/2023
Researchers may be able to predict cardiovascular disease – such as atrial fibrillation and heart failure – in patients by using artificial intelligence (AI) to examine the genes in their DNA, according to a new Rutgers study.
Researchers may be able to predict cardiovascular disease – such as atrial fibrillation and heart failure – in patients by using artificial intelligence (AI) to examine the genes in their DNA, according to a new Rutgers study.
Researchers may be able to...
02/28/2023
Cath Lab Digest

Advertisement

News
Certain Reproductive Factors in Women Contribute to Risk of Cardiovascular Disease
02/28/2023
An earlier first birth, a higher number of live births, and starting periods at a younger age are all linked to a higher risk of cardiovascular problems in women, according to new research.
An earlier first birth, a higher number of live births, and starting periods at a younger age are all linked to a higher risk of cardiovascular problems in women, according to new research.
An earlier first birth, a higher...
02/28/2023
Cath Lab Digest
News
CRT 2023 Late-Breaking Data: CoreValve/Evolut Platform Demonstrates Significantly Lower Bioprosthetic Valve Dysfunction Compared to Surgery at Five Years
02/27/2023
Medtronic announced five-year bioprosthetic valve dysf­unction (BVD) data for the CoreValve/Evolut  platform, the first and only transcatheter aortic valve replacement (TAVR) platform to show significantly better valve performance...
Medtronic announced five-year bioprosthetic valve dysf­unction (BVD) data for the CoreValve/Evolut  platform, the first and only transcatheter aortic valve replacement (TAVR) platform to show significantly better valve performance...
Medtronic announced five-year...
02/27/2023
Cath Lab Digest
News
The Texas Heart Institute Delivers a New First in Heart Failure Treatment Using Cell Therapy
02/27/2023
The therapy benefited patients by improving ejection fraction, and reducing the risk of heart attack or stroke, especially in patients who have high levels of inflammation.
The therapy benefited patients by improving ejection fraction, and reducing the risk of heart attack or stroke, especially in patients who have high levels of inflammation.
The therapy benefited patients...
02/27/2023
Cath Lab Digest

Advertisement

News
FEops HEARTguide Proven to Significantly Enhance Efficiency and Outcomes of LAA Closure Procedures.
02/27/2023
GENT, Belgium — FEops announced the publication of the PREDICT-LAA study in JACC: Cardiovascular Interventions, showing that Left Atrial Appendage Closure (LAAC) procedures planned by means of FEops HEARTguide™ resulted in significant...
GENT, Belgium — FEops announced the publication of the PREDICT-LAA study in JACC: Cardiovascular Interventions, showing that Left Atrial Appendage Closure (LAAC) procedures planned by means of FEops HEARTguide™ resulted in significant...
GENT, Belgium — FEops announced...
02/27/2023
Cath Lab Digest
News
CRT 2023 selects Syntach Cardiac Support System for Best Innovation Competition
02/27/2023
Syntach AB ("Syntach") is pleased to announce that the Company's Syntach Cardiac Support system (Syntach CS) has been selected for an oral presentation in the Best Innovation Competition to be held during the CRT 2023 annual meeting.
Syntach AB ("Syntach") is pleased to announce that the Company's Syntach Cardiac Support system (Syntach CS) has been selected for an oral presentation in the Best Innovation Competition to be held during the CRT 2023 annual meeting.
Syntach AB ("Syntach") is...
02/27/2023
Cath Lab Digest
News
CRT 2023: Study Demonstrates Successful Device Size Selection When Assessing Left Atrial Appendage by Angiography Compared to TEE
02/27/2023
The CONFORMAL Early Feasibility Study (EFS) evaluated the use of angiography compared to transesophageal echocardiogram (TEE) for left atrial appendage (LAA) assessment.
The CONFORMAL Early Feasibility Study (EFS) evaluated the use of angiography compared to transesophageal echocardiogram (TEE) for left atrial appendage (LAA) assessment.
The CONFORMAL Early Feasibility...
02/27/2023
Cath Lab Digest

Advertisement

News
ACC: Clinical Trials Often Overlook People with Disabilities
02/24/2023
Disabilities were underreported in clinical trial data and commonly used as a basis for exclusion from trial participation in an analysis of 80 recent trials involving cardiovascular outcomes.
Disabilities were underreported in clinical trial data and commonly used as a basis for exclusion from trial participation in an analysis of 80 recent trials involving cardiovascular outcomes.
Disabilities were underreported...
02/24/2023
Cath Lab Digest
News
ACC: Insomnia Tied to Greater Risk of Heart Attack, Especially in Women
02/24/2023
People who suffer from insomnia were 69% more likely to have a heart attack compared to those who didn’t have the sleep disorder during an average nine years of follow-up.
People who suffer from insomnia were 69% more likely to have a heart attack compared to those who didn’t have the sleep disorder during an average nine years of follow-up.
People who suffer from insomnia...
02/24/2023
Cath Lab Digest

Advertisement

Advertisement

Subscriber

Cath Lab Digest Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use